LFWDLFWDHealthcare · Medical Devices

LFWD Stock Forecast: Lifeward Ltd. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$2.80
−4.98% on the day

The median 12-month analyst price target for Lifeward Ltd. is $8.5. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 15 of 100 as at 21 Nov 2026 — in the weakest quartile.

Market cap
$8.0M
Ticker Nerd rank
15/ 100
Median analyst target
$8.50
Analysts covering
2
Revenue$6.6M+15.7% y/y
Operating income−$4.2M
Net income−$11.5M
Free cash flow−$6.0M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−31.0%
1M
−50.0%
YTD
−59.5%
1Y
−55.1%
From 52W high
−69.3%
From 52W low
0.0%
$2.80
$9.12
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores Lifeward Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
15/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
56
Growth
50
Volatility
28
Momentum
25
Quality
23
Revisions
21
Value
21
Issuance
4

Accruals (56): Reported profit is backed by cash, and the company is not expanding recklessly.

Issuance (4): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

LFWD stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on LFWD, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$2.00$4.00$6.00$8.00$10.00Jan 26Apr 26Jul 26Oct 26LFWDHigh $9.00Median $8.50Low $8.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says2 analysts
2
Buy
0
Hold
0
Sell
$8.00
Low
$8.50
Median
$9.00
High
Recent analyst actionsNewest first
DateFirmActionRatingTarget
16 Nov 2026HC Wainwright & Co.MaintainsBuy$10 → $8.00
19 Mar 2026HC Wainwright & Co.MaintainsBuy$4.50 → $10
18 Nov 2025HC Wainwright & Co.MaintainsBuy—
11 Mar 2025HC Wainwright & Co.ReiteratesBuy—
11 Mar 2025Lake StreetMaintainsBuy—
20 Feb 2025HC Wainwright & Co.ReiteratesBuy—
20 Feb 2025Lake StreetMaintainsBuy—
10 Feb 2025Laidlaw & Co.InitiatesBuy—
13 Nov 2024HC Wainwright & Co.ReiteratesBuy—
16 Aug 2024HC Wainwright & Co.MaintainsBuy—
16 May 2024HC Wainwright & Co.MaintainsBuy—
15 Apr 2024HC Wainwright & Co.ReiteratesBuy—
28 Feb 2024HC Wainwright & Co.ReiteratesBuy—
15 Nov 2023HC Wainwright & Co.ReiteratesBuy—
14 Aug 2023HC Wainwright & Co.ReiteratesBuy—
10 Aug 2023HC Wainwright & Co.ReiteratesBuy—
3 July 2023HC Wainwright & Co.ReiteratesBuy—
12 May 2023HC Wainwright & Co.ReiteratesBuy—
24 Feb 2023HC Wainwright & Co.ReiteratesBuy—
15 Nov 2022HC Wainwright & Co.MaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for LFWD.

Market Radar

This page is one stock. Monday covers all of them.

LFWD appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

LFWD vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, Lifeward Ltd. returned −55.1% against +6.9% for the S&P 500, dividends included.

LFWD vs S&P 500, last 12 monthsTotal return, rebased to 100
406080100120140Jan 26Apr 26Jul 26Oct 26LFWDS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

LFWD analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
Analysts raising
0
Analysts cutting
1
Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
0.4×

Cheaper than 83% of US stocks

Price / book
1.1×

Cheaper than 68% of US stocks

EV / EBITDA
—
Growth & margins
Revenue growth (YoY)
—
Earnings growth (YoY)
—
Gross margin
40.9%

Higher than 51% of US stocks

Operating margin
—
Net margin
—
Returns & dividend
Return on equity
−326.8%

Higher than 4% of US stocks

Return on assets
−61.0%

Higher than 6% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Lifeward Ltd. has a market value of $8.0M and an enterprise value of $13.0M.

  • Revenue in the twelve months to 30 June 2026: $21.8M. The latest quarter grew 15.7% year on year.

  • Net income over the same four quarters: −$30.8M, a −141.3% net margin.

  • Diluted earnings per share, trailing twelve months: −$16.82.

  • Free cash flow in the twelve months to 30 June 2026: −$17.1M.

  • Shares outstanding: 2.8M.

  • Lifeward Ltd. employs 81 people — $269K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 21 Nov 2026

Data provided by Twelve Data

Peers

LFWD and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
LFWDLifeward Ltd.$8.0M15
IRIXIRIDEX Corp.$7.6M47
SINTSINTX Technologies, Inc.$8.3M41
AEMDAethlon Medical, Inc.$8.8M24
PAVMPAVmed, Inc.$9.1M31
ARAYAccuray, Inc.$6.2M46
HSCSHeartSciences, Inc.$10.3M43

Take a look at LFWD’s peer groups, ranked by the model: healthcare stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own Lifeward Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about LFWD

What is the LFWD stock price forecast for 2026-2027?

The median 12-month analyst price target for Lifeward Ltd. is $8.5, with estimates ranging from $8 to $9. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is LFWD stock a buy right now?

Of the 2 analysts covering Lifeward Ltd., 2 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Lifeward Ltd. 15 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank LFWD?

As at 21 Nov 2026, Lifeward Ltd. ranks 15 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Accruals (56 of 100).

Will LFWD stock go up?

No one can know that. What the data says: the median 12-month target from 2 analysts is $8.5, and Ticker Nerd's factor model ranks Lifeward Ltd. 15 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the LFWD stock forecast for 2030?

No analyst covering Lifeward Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for LFWD are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $8 to $9 over the next 12 months.

How has LFWD stock performed over the past year?

Lifeward Ltd. returned -55.1% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Lifeward Ltd. do?

Lifeward Ltd. is a medical device company that develops and commercializes rehabilitation technologies designed to improve mobility and support recovery for people with physical and neurological conditions. Its portfolio includes wearable robotic exoskeletons and related systems used in clinical, home, and community settings.

Company

About Lifeward Ltd.

Lifeward Ltd. is a medical device company that develops and commercializes rehabilitation technologies designed to improve mobility and support recovery for people with physical and neurological conditions. Its portfolio includes wearable robotic exoskeletons and related systems used in clinical, home, and community settings. Key products include the ReWalk personal exoskeleton, the ReStore soft exo-suit, the AlterG Anti-Gravity System, and MyoCycle devices, which are used in physical rehabilitation, post-stroke recovery, and mobility training. The company also serves institutions and individual users through direct sales and third-party distribution channels. Lifeward Ltd. operates across markets in the United States, Europe, and the Asia-Pacific region, positioning itself within the broader medical technology and rehabilitation equipment sector.

CEO Mr. Joshua Hexter · 81 employees · Israel · https://golifeward.com